An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects

Clinical trial NCT03082937 · COMPLETED

Trial details

NCT number: NCT03082937
Sponsor: Albireo
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Orphan Cholestatic Liver Diseases Progressive Familial Intrahepatic Cholestasis Alagille Syndrome Primary Biliary Cirrhosis

Start date: 2017-01-31
Primary completion: 2017-03-08
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.